- £98.41m
- £105.20m
- $167.90m
- 56
- 82
- 58
- 76
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 190 | 142 | 134 | 199 | 168 |
Cost of Revenue | |||||
Gross Profit | 61.1 | 18.2 | 19.5 | 82.3 | 56.7 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 168 | 379 | 89.1 | 99.7 | 187 |
Operating Profit | 21.3 | -237 | 45 | 99.4 | -18.7 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 11.7 | -241 | 38.6 | 80.6 | -29 |
Provision for Income Taxes | |||||
Net Income After Taxes | -26.5 | -216 | -4.7 | 24.4 | -48.8 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -24.5 | -216 | -4.7 | 24.4 | -48.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -24.5 | -216 | -4.7 | 24.4 | -48.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.041 | -0.15 | -0.068 | 0.025 | -0.014 |
Dividends per Share |